retatrutide clinical trial results weight loss 2024 2025 press release There is a new shot moving through trials and the numbers are bigger than anything we have seen. It is called Retatrutide. At the highest dose people lost 30 percent Lilly's triple agonist delivers up

*Compounded medications are not reviewed by the FDA for safety or efficacy and are only available to patients for whom a licensed prescriber has determined your unique medical needs cannot be met by commercially available pharmacotherapies.

Using a U-500 syringe for a GLP-1 medication would deliver five times the intended dose

You still want to have a slow, steady weight loss with slow dose titration

Access and affordability may vary

B12 deficiency isn't necessarily marked by any one symptom in particular

Nguyen AT, Mandard S, Dray C et al (2013) Lipopolysaccharides-Mediated increase in glucose-stimulated insulin secretion : involvement of the GLP-1 pathway